Skip to content

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery Through Tubeless Laparoscopic Adrenalectomy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06250699
Enrollment
200
Registered
2024-02-09
Start date
2024-01-03
Completion date
2027-06-30
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cushing Syndrome, Nonfunctional Adrenal Cortex Adenoma, Primary Aldosteronism

Keywords

tubeless, laparoscopic adrenalectomy, rapid recovery

Brief summary

The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are: 1. The safety of tubeless laparoscopic adrenalectomy; 2. The role of tubeless therapy in rapid recovery after adrenalectomy surgery Participants will be randomly divided into two groups: the non drainage group and the drainage group after laparoscopic adrenal surgery, and their pain, first time out of bed, and intestinal recovery time will be observed.

Detailed description

The design type of this study is a prospective single center randomized controlled study, with a plan to recruit 200 patients who underwent laparoscopic adrenalectomy for the study. The intervention measures mainly include whether to indwelling drainage tubes. Prior to the start of the trial, our center had performed laparoscopic adrenalectomy on 89 patients without any obvious retroperitoneal fluid accumulation, redness, swelling, or fever, and the recovery was smooth. Step 1 of the research: Select patients who meet the criteria for laparoscopic adrenalectomy Step 2: Sign informed consent form Step 3: Randomly draw lots and divide them into two groups: no tube group (experimental group of 100 cases) and indwelling drainage tube group (control group of 100 cases) Step 4: Perform surgical plan according to grouping results Step 5: Test blood routine and ERAS related indicators 1-3 days after surgery Step 6: Follow up adrenal ultrasound at 1 month and 6 months after surgery Step 7: Follow up and analyze data Random plan Use block randomization method, using software SAS9.4 TS1M7, random seed number 2023092311 Observation items and testing time points 1. Test hemoglobin and drainage volume on 1-3 days after surgery Pain score, first time out of bed, intestinal ventilation time, adrenal ultrasound, postoperative fever, wound infection, and other indicators; During the follow-up one month after surgery, the adrenal region color ultrasound should also be tested; 3. During the follow-up examination at 6 months after surgery, ultrasound of the adrenal region should also be detected; Efficacy evaluation criteria and effectiveness evaluation methods: Whether the indwelling drainage tube has a promoting effect on the patient's rapid recovery (such as pain score, first time out of bed, intestinal ventilation time, etc.). Safety evaluation methods mainly include the subject's blood routine and vital signs.

Interventions

PROCEDURETubeless laparoscopic adrenalectomy

No drainage tube placed after laparoscopic adrenalectomy

PROCEDUREDrainage tube

Placing drainage tubes after laparoscopic adrenalectomy

Sponsors

Zhe Meng
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications 2. The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old.

Exclusion criteria

1. Patients with complications that seriously affect treatment or quality of life 2. The patient has any physical condition that the researcher believes will affect the clinical status 3. Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year 4. Pregnant or lactating patients

Design outcomes

Primary

MeasureTime frameDescription
Pain score1-3 days after surgeryPain rating scale after laparoscopic adrenalectomy by VAS(visual analog scale for pain ) scale. The score ranges from 1 to 10, and the degree of pain gradually increases.
First time up and about1-3 days after surgeryFirst time up and about after laparoscopic adrenalectomy
Recovery time of intestinal function1-3 days after surgeryRecovery time of intestinal function after laparoscopic adrenalectomy
Hematoma1-3 days after surgeryDetection of obvious hematoma (Hematoma area\> 4cm x 4cm) in the surgical area through color ultrasound. The results are expressed as yes or no.

Secondary

MeasureTime frameDescription
fever1-3 days after surgeryDoes the patient experience fever (The thermometer shows a temperature greater than 37.3 ° C) after laparoscopic adrenalectomy.

Countries

China

Contacts

Primary Contactmeng zhe
mengzhe@whu.edu.cn15387041020

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026